Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AGAP7P (ArfGAP with GTPase domain, ankyrin repeat and PH domain 7, pseudogene) is an annotated human pseudogene predicted from sequence analysis to resemble the AGAP family, with ankyrin repeats, a Pleckstrin homology domain, and a GTPase domain. It is classified as a pseudogene because it does not encode a functional protein product—though some pseudogenes can be transcribed, most lack detectable protein-coding activity and do not fulfill typical receptor, enzyme, or transporter functions in biology. Its existence is inferred from genomic sequence and homology to protein-coding genes in the AGAP family, but there is no experimental evidence for its biological function, interaction with drugs, or involvement in disease. If you require information for a canonical functional target—such as a receptor, enzyme, or transporter—this entry should be considered incorrect for therapeutic targeting purposes as it refers to a non-coding pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ArfGAP with GTPase domain, ankyrin repeat and PH domain 7, pseudogene (AGAP7P).